SyntheticMR announced that their quantitative imaging software solution SyMRI 12.1 has received regulatory approval in South Korea according to KFDA (Korea Food & Drug Administration). This means that SyMRI 12.1 now can be sold and distributed in this market. SyMRI NEURO is designed to help save valuable time by reducing scan time, all the while aiding as an objective decision support for diagnosis and patient follow-ups.

A single fast scan offers a fast and standardized protocol with clinically relevant quantitative data for more robust assessments of patients. Additionally, SyMRI NEURO provides automatic segmentation of tissue such as myelin volumes, quantification of white matter, gray matter, cerebrospinal fluid and brain parenchymal volume. SyMRI MSK provides more information in less time.

One single fast scan produces quantitative T1, T2, and PD maps and a series of contrast-weighted images, for both clinical use and advanced research. SyMRI MSK also gives the radiologist more control over the image quality by making it possible to change TE, TR, and TI post-scan.